Flomatrix
Flomatrix is a Brisbane-based medical technology company founded in 2018, dedicated to developing innovative IV catheter tip technology to reduce high failure rates of IV cannulas. Their patented designs aim to improve clinical success, reduce costs, and minimize patient discomfort by dramatically reducing mechanical forces that contribute to inflammation and device failure. The company is committed to improving vascular access outcomes through novel device design and regulatory pathways that facilitate market entry.
Industries
Nr. of Employees
small (1-50)
Products
Patented ramped-tip peripheral IV catheter concept
A ramped internal-tip design for peripheral IV catheters that redirects infused fluid toward the centre of venous flow to reduce mechanical forces on the vein; supported by published comparative data.
Patented ramped-tip peripheral IV catheter concept
A ramped internal-tip design for peripheral IV catheters that redirects infused fluid toward the centre of venous flow to reduce mechanical forces on the vein; supported by published comparative data.
Services
IP licensing and integration consulting
Licensing of catheter tip intellectual property and support for integrating the design into existing manufacturer product ranges.
Comparative performance testing and validation support
Bench testing, comparative device studies, and preclinical assessments (including histopathology) to evaluate infusion device performance.
Regulatory pathway advisory for IV catheter integration
Advisory services on regulatory strategy for integrating tip technology into existing catheter product lines with attention to possible 510(k) implications.
Commercialisation support and accelerator engagement
Support for device commercialisation including participation in accelerator programs and market entry planning.
IP licensing and integration consulting
Licensing of catheter tip intellectual property and support for integrating the design into existing manufacturer product ranges.
Comparative performance testing and validation support
Bench testing, comparative device studies, and preclinical assessments (including histopathology) to evaluate infusion device performance.
Regulatory pathway advisory for IV catheter integration
Advisory services on regulatory strategy for integrating tip technology into existing catheter product lines with attention to possible 510(k) implications.
Commercialisation support and accelerator engagement
Support for device commercialisation including participation in accelerator programs and market entry planning.
Expertise Areas
- Vascular access device design
- Clinical trial management for vascular access devices
- Device validation and comparative performance testing
- Regulatory assessment for 510(k) pathway integration
Key Technologies
- Ramped internal-tip catheter geometry
- Fluid mechanics for infusion device optimisation
- Bench comparative testing for device performance
- Histopathology for device-related tissue assessment